Related Experiment Videos
Treatment of hypertension with a new beta-blocking agent, pindolol (Visken)
European Journal of Clinical Pharmacology
|December 1, 1973
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Coprecipitation of Ce(III) oxide with UO2.
Journal of synchrotron radiation·2024
Ti C MXenes with fully saturated and thermally stable Cl terminations.
Nanoscale advances·2022
Quality Indicators of Nutritional Care Practice in Elderly Care.
The journal of nutrition, health & aging·2017
Real-world pharmacogenomics-guided antihypertensive treatment response in clinical practice underrepresented population: implications for precision prescribing and medication safety.
European journal of clinical pharmacology·2026
Response to alemtuzumab-based therapy and long-term survival after allogeneic transplantation in T-Cell prolymphocytic leukemia: a systematic review and meta-analysis of proportions.
European journal of clinical pharmacology·2026
Association between body mass index and serum concentrations of olanzapine and selective serotonin reuptake inhibitors in patients with eating disorders.
European journal of clinical pharmacology·2026
Clobazam in pediatric drug-resistant epilepsy: from pharmacology to clinical practice.
European journal of clinical pharmacology·2026
Response to "Comment on cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults - results from the ActiFE study".
European journal of clinical pharmacology·2026
Recent research progress on the mechanisms of clopidogrel resistance.
European journal of clinical pharmacology·2026
Sarcolipin is a Conformation-Dependent Regulator of the Sarcoplasmic Reticulum Calcium Pump SERCA.
The Journal of membrane biology·2026
Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.
Journal of immunology (Baltimore, Md. : 1950)·2026
Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.
Handbook of experimental pharmacology·2026
Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?
The Journal of clinical endocrinology and metabolism·2026